ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,537.02
      0.51%
      US Tech 100
      19,641.60
      0.83%
      Dow Jones
      39,308.00
      -0.06%
      Brent Oil
      86.705
      -0.24%
      Bitcoin
      58,910.92
      -2.08%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Galectin Therapeutics Inc (GALT)

      7. Galectin Therapeutics Inc (GALT) News

      GALT

      Galectin Therapeutics (GALT)

      Galectin Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GALT
      DateTimeSourceHeadlineSymbolCompany
      1:00PMiHub NewswireFeaturedFreedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent
      07/09/20218:00AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GALTGalectin Therapeutics Inc
      07/09/20218:00AMGlobeNewswire Inc.Galectin Therapeutics Announces Positive Top-Line Results from a Phase 1b Clinical Trial Extension of Belapectin in Combinati...NASDAQ:GALTGalectin Therapeutics Inc
      07/02/20218:01AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      06/16/20218:01AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      06/03/20215:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      06/01/20219:31AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      05/17/20214:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      05/17/20218:00AMGlobeNewswire Inc.Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2021, and Provides Business UpdateNASDAQ:GALTGalectin Therapeutics Inc
      05/17/20217:57AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GALTGalectin Therapeutics Inc
      05/17/20217:55AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GALTGalectin Therapeutics Inc
      05/05/202112:06PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:GALTGalectin Therapeutics Inc
      05/03/20215:00PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      04/27/20219:27AMGlobeNewswire Inc.Galectin Therapeutics to Present at 4th Global NASH CongressNASDAQ:GALTGalectin Therapeutics Inc
      04/19/20215:00PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      04/19/20218:00AMGlobeNewswire Inc.World-Renowned Neurosurgeon Dr. Ben Carson, Sr. Joins Galectin Therapeutics as Special Consultant to Accelerate and Enhance D...NASDAQ:GALTGalectin Therapeutics Inc
      04/19/20217:51AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GALTGalectin Therapeutics Inc
      04/13/20217:01PMGlobeNewswire Inc.Journal for ImmunoTherapy of Cancer Publishes Phase 1 Clinical Research Showing Belapectin, Galectin Therapeutics’ Galectin...NASDAQ:GALTGalectin Therapeutics Inc
      04/06/20218:00AMGlobeNewswire Inc.Galectin Therapeutics Launches NAVIGATEnash.com, a Resource for Both Patients and Physicians about its Innovative NASH Cirrho...NASDAQ:GALTGalectin Therapeutics Inc
      04/05/20211:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      03/31/20215:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      03/31/20214:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      03/31/20214:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      03/31/20214:31PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GALTGalectin Therapeutics Inc
      03/31/20214:31PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GALTGalectin Therapeutics Inc
      03/31/20218:00AMGlobeNewswire Inc.Galectin Therapeutics Reports Fiscal 2020 Financial Results and Provides Business UpdateNASDAQ:GALTGalectin Therapeutics Inc
      03/31/20217:53AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GALTGalectin Therapeutics Inc
      03/31/20217:52AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:GALTGalectin Therapeutics Inc
      03/16/20219:16AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      03/09/20217:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GALTGalectin Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:GALT